Loading company…
Provides genomic and liquid biopsy tests and AI tools for precision oncology.
OneCell Diagnostics provides precision oncology tests and tools, including genomic profiling, liquid biopsy, hereditary cancer testing, and AI analysis. Its customers include oncologists, hospitals, and research institutions. Founded in 2021, the company is based in Mumbai, India. In November 2024, it raised USD 16 million in series A funding led by Celesta Capital, with Singularity Ventures, Tenacity Ventures, Cedars-Sinai Health System, and Eragon participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in